Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections.

Infect Drug Resist · 2011 · PMC3108747 · PMID 21694912

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Those trends were strongest in the MRSA and MSSA subsets, but they did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.